Introduction
Hepatocellular carcinoma (HCC) accounts for 84% of malignant hepatic neoplasms and ranks as the third most fatal form of neoplasia. HCC is associated with chronic inflammatory liver disease when also exposed to hepatocarcinogens (e.g. aflatoxin B1) or chronic infection with hepatitis viruses (hepatitis B virus (HBV) or hepatitis C virus). How the risk factors lead to HCC is complex and only partially elucidated. Recent cDNA microarray analyses have demonstrated in HCC deregulation of genes involved in cell cycle regulation and genes regulated by liver-enriched transcription factors (Xu et al., 2001a, b) , implicating complex involvement of multiple regulatory pathways.
Noncoding RNAs (ncRNAs) are abundant. Recently, numerous microRNAs (miRNAs), a class of small ncRNAs, have been identified and implicated in key roles in certain biological processes (Bartel, 2004) . miRNAs are also linked to neoplastic transformation (Lu et al., 2005; Meltzer, 2005; Volinia et al., 2006) . In addition, one type of ncRNAs transcribed from the introns of known genes correlate with the degree of differentiation of prostate cancer (Reis et al., 2004) or protect cells from Fas-mediated apoptosis (Yan et al., 2005) . Another class of ncRNAs that have received relatively sparse attention are the large ncRNAs that, like mRNAs, are usually produced by RNA polymerase II, but lack significant and utilized open reading frames (ORFs). They appear to exert functional roles directly as ncRNAs and some have been identified to function as genetic regulators or riboregulators (Erdmann et al., 2001) . Recent genomic and transcriptomic projects have unraveled an unexpectedly large number of large ncRNAs in the human (Scherer et al., 2003; Ota et al., 2004) and mouse (Okazaki et al., 2002; Carninci et al., 2005) genomes. The FANTOM consortium annotated 33 409 murine transcriptional units representing 60 770 full-length cDNA sequences. Whereas about half (17 594) of the transcriptional units had coding potential, the other half (15 815) were candidate ncRNAs (Okazaki et al., 2002) . Except for the clear difference between the percentage of unspliced/single exons for the transcripts, they were similar in terms of average length (1.9 kb for the noncoding versus 2.1 kb for the coding RNAs), and percentage of polyA tails and polyA signals. Some candidate ncRNAs in the collection were isolated from tissue-specific and stagespecific libraries, suggesting possible involvement in differentiation and development (Numata et al., 2003) .
Despite the existence of a sizable population of large ncRNAs, disproportionally few studies have investigated their functions. One of the better elucidated large ncRNAs is Xist (X chromosome inactive specific transcript) that presents as a 17-kb (human) and a 15-kb (mouse) molecule responsible for somatic X-chromosome dosage compensation (Brockdorff et al., 1992; Brown et al., 1992; Plath et al., 2002) . Another example is a paternally imprinted gene H19 (O'neill, 2005) , with a conserved secondary structure but non-conserved ORFs, that functions as a tumor suppressor in some tumor types and may play a significant role in tumorigenesis in other types (Steenman et al., 1994; Lottin et al., 2002; Manoharan et al., 2003) . Recently, Willingham et al. (2005) identified an ncRNA designated NRON that is a repressor of nuclear factor of activated T cells.
We have identified a gene encoding a large ncRNA that appears to be the murine ortholog of the human alpha gene, that is, MALAT-1, that is upregulated in metastasizing human non-small-cell lung carcinomas (Ji et al., 2003) , and is evolutionarily conserved among mammals. The large ncRNA transcript, Hepcarcin (HCN), is highly expressed in murine HCCs induced with a procarcinogen as well as in human HCCs and may represent an informative marker for HCCs. It is overexpressed in all five non-hepatocellular human carcinomas analysed. Thus, it appears to be a more general marker for carcinomas with the potential to play a broad role in the molecular cell biology of neoplasia. We also introduce a murine model for investigation of the functions of this ncRNA as well as its potential role in neoplasia.
Results
Discovery of the large RNA transcript DP100, a B360 bp RNA hit, was initially identified by differential display analysis of isolated CD31-enriched endothelial cells from a syngeneic murine colon carcinoma. It was subsequently observed in the tumor cells as well. Northern blots revealed that the full-length transcript is a 7-kb RNA (Figure 1a) . The gene encoding the full-length transcript was designated hcn. The gene was characterized by a combination of 5 0 RACE, reverse transcription-polymerase chain reaction (RT-PCR) analysis coupled with bioinformatic search, 3 0 RACE and DNA sequencing ( Figure S1 ). To substantiate identification of the transcript, primer sets were designed to amplify 99% of the length of the hcn gene corresponding to the 5 0 end to bp6930. An RT-PCR product of expected size was generated (Figure 1b , lane 1) and the previously determined HCN ncRNA sequence was confirmed. Comparison of the sequence of the RT-PCR HCN product and the hcn genomic sequence provided no evidence of RNA splicing. The control reactions without RT produced no band ( Figure 1b , lane 2), whereas addition of the genomic DNA generated a band coincident with the RT-PCR product (Figure 1b, lanes 3 and 1) , confirming the absence of splicing or processing of the RNA. In addition, three antisense probes corresponding to the 5 0 end (1AS), the middle (2AS) and the 3 0 end (3AS) HCN transcript were used for Northern blot analysis. The middle 2AS probe also included part of the possible ORF (Figure 2b and d) . Figure 1c shows that all three probes yielded the same results as the original AS probe (Figure 1a) , consistent with identification of HCN as a 7-kb unspliced transcript. The 7-kb hcn gene mapped to mouse chromosome 19A.
HCN is a conserved large ncRNA Blastn search of different segments of the hcn gene sequence revealed a significant degree of identity among mammalian cDNA or RNA hits (Figure 2a , top), consistent with potential functional importance. The phylogenetic relationship of the corresponding segments of the cDNA hits from each species with the highest scores are shown in a guide tree (Figure 2a , bottom). GI 6979641 (GenBank acc # AF203815), an 8.6-kb intronless human gene (designated alpha gene) (van Asseldonk et al., 2000) , exhibits 60.7% identity to the full-length hcn. Alpha gene was renamed MALAT-1 based on its association of metastasis with human lung adenocarcinomas (Ji et al., 2003) . The full-length hcn gene is homologous to only one genomic contig from the National Center for Biotechnology Information (NCBI) human genome database, namely NT_033903.7 that contains the MALAT-1 gene on human chromosome 11q13. The local orders of genes flanking hcn at murine chromosome 19A and MALAT-1 at human chromosome 11q13 are similar (data not shown). Thus, hcn appears to be the murine ortholog of MALAT-1.
Analysis of sequences of the 7-kb hcn as well as its mammalian homologs failed to predict a protein of more than 80 amino acids. The longest ORF of hcn was 195 bp (Figure 2b ). Even so, it did not contain a valid Kozak sequence, suggesting the unlikelihood of translation. Additionally, the predicted protein did not exhibit significant similarity to any known protein or protein domain (Figure 2b ). Searches of other predicted proteins from the hcn and its homologs gave the same results (data not shown). Thus, the HCN transcript is consistent with a large ncRNA. Comparative genomic analysis is an indispensable tool in distinguishing a protein-coding gene from a ncRNA gene by determining whether the ORF is significantly conserved and whether the pattern of mutation favors synonymous and conservative amino-acid changes (Eddy, 2001) . Significantly, cross comparisons of all the predicted proteins of hcn and its homologs showed little similarity. Figure 2c shows the alignment of the putative proteins with the highest identity after exhaustive comparisons. The only potential ORF sequence of hcn ('mouse') showed modest similarity with that of rat (GI 59861852, 'rat') ( Figure 2c, italics) . The DNA sequences of these two genes were 100% identical in the conserved regions (Figure 2d, italics) , suggesting the absence of synonymous changes. For the nucleotide sequences that do not match in these putative protein coding regions, the mismatches exclusively localized in either the putative first or second but not the third base of codons (Figure 2d ), resulting in amino-acid alterations ( Figure 2c ) and exhibited no synonymous changes. Comparison of the putative proteins encoded by the hcn orthologs in human (GI 6979641, bp4330-4770) and orangutan (GI 55726753, bp1468-1626 showed similar results ( Figure 2c and data not shown). Finally, there was little similarity of the putative proteins among hcn homologs for all four species (Figure 2c ). Taken together, these results strongly indicate that there was no selection pressure to conserve the ORF sequences and putative proteins, consistent with the identity of HCN as a ncRNA rather than a protein encoding mRNA. Indeed, in vitro transcription and translation of a MALAT-1 gene sequence failed to generate any peptide or protein (Ji et al., 2003) . A search against a database of miRNAs failed to identify known miRNAs identical to any part of the sequence of hcn, inferring that the HCN transcript functions as a large ncRNA and is not processed to one or more miRNAs.
HCN as a marker for procarcinogen-induced murine HCC The HCN transcript was highly expressed in murine CT26 tumors, but was barely detectable in normal liver tissue (Figure 3a) , consistent with a model suitable for analysis on the basis of association of this transcript with neoplasia. An experimental model has been established in which the procarcinogen diethylnitrosamine (DEN) induces HCC in mice . Multiple HCC nodules are observed within the liver 8 months after DEN administration (Figure 3b, top left) . Strikingly, in situ hybridization (ISH) analysis with the AS probe showed that tumor cells of all 11 HCCs from three mice contained prominent HCN transcripts, whereas the surrounding normal hepatocytes had little, if any, HCN RNA (Figure 3b, top right, bottom left) . Hybridization with the 3AS antisense probe against the 3 0 end produced identical results (data not shown). Two negative controls, one hybridized with the sense probe (S) of the hcn gene and one treated with RNase before hybridizing with the AS probe, were negative (data not shown). The results indicate that the HCN transcript is a robust marker for these hepatic tumors. The HCN transcript is dominantly localized in nuclei of the majority of the tumor cells (Figure 3b , bottom right), and clearly concentrated in nucleoli of some cells. Northern blotting demonstrated that HCN was greatly increased in liver tumors compared with the surrounding normal liver (Figure 3c) , with approximately an eightfold difference.
MALAT-1 as a marker for human HCC To explore the biology of this large ncRNA and consider the potential significance in human, we examined the expression of MALAT-1 in human HCC samples using total RNAs from either normal human liver or human HCC (Figure 4a ). An RNA antisense probe (hAS) corresponding to bp6268-6621 of GI 6979641 hybridized with a single RNA band that migrated slower than a 7-kb marker (Figure 4b, top) . Strikingly, the expression levels of the large ncRNA in HCC were about sixfold greater than in normal liver (Figure 4b, bottom) . This is consistent with the ortholog MALAT-1 as a marker for human HCC.
We examined expression of the gene in human HCC samples using liver tissue arrays in which one slide contained four sets of HCC samples with the corresponding normal liver tissues. The HCCs were in different stages of tumor development (Figure 4c) . ISH with the hAS probe detected little or only traces of MALAT-1 transcripts in all non-tumor liver sections (Figure 4d, left panels) . All of the HCC areas, including the early stages of HCC development, exhibited prominent hybridization to the transcript (Figure 4d , right panels). The transcript appeared to be predominantly localized in nuclei of tumor cells (Figure 4d , bottom right). All three HCC samples in another array slide overexpressed the transcript compared with the corresponding non-tumor liver (data not shown). All four non-tumor liver samples from an array slide of HCCs with HBV exhibited negative hybridization, whereas 97 of 100 HCC samples had very strong hybridization and the remaining three showed tracepositive MALAT-1 hybridization (data not shown). MALAT-1 expression in human carcinomas versus the corresponding non-tumor tissues was considered significant with Po0.05 by w 2 analysis.
MALAT-1 as a potential generic marker for human carcinomas To explore whether this large ncRNA is a broad marker for neoplasia, we analysed expression by ISH with the hAS probe using a set of non-hepatic human carcinoma tissue array slides with corresponding tissue controls. MALAT-1 positivity was scored (undetectable or low 0, moderate 1, strong 2 or very strong 3). The majority of non-tumor samples showed negative or low expression for MALAT-1, the majority of breast, pancreas and lung carcinomas, and about half of colon and prostate carcinomas exhibited moderate to very strong MALAT-1 RNA ( Figure 5 ). Fifty to 80% of analysed cases of colon, lung, pancreas and breast cancer exhibited significantly increased hybridization intensity for this large ncRNA compared with the surrounding normal tissues (Table S1 ). About a quarter of analysed samples of prostate cancers also exhibited elevated hybridization of the transcript. As in HCCs, the transcript also predominantly localized in nuclei of the other five types of carcinomas (data not shown). Strikingly, in all 111 samples from all of the six cancer types analysed, no tumor samples exhibited decreased hybridization of the transcript compared with the corresponding non-tumor samples. Thus, this large ncRNA appears to be a marker for all of the six types of carcinomas analysed. 
Discussion
Tumor markers not only provide potential targets for diagnosis and therapeutic intervention, but also directly facilitate advanced understanding of the molecular cell biology of neoplasia. Highly characteristic molecular markers specific for most solid tumors remain elusive; and no robust markers from 16 063 mRNAs analysed exhibit consistent differential expression between 218 tumors and 90 normal tissues (Ramaswamy et al., 2001) . On the other hand, more recent studies from this and other groups demonstrate that expression profiles of miRNAs are significantly altered in human neoplasms, and can be used to distinguish tumors from normal tissues (Lu et al., 2005; Volinia et al., 2006) , which supports the potential for some ncRNAs in tumor diagnosis and functional characterization. The present study identified a large ncRNA, HCN in the mouse and the ortholog MALAT-1 for humans, that clearly distinguishes six classes of carcinomas from their corresponding normal tissues, indicating a potentially generic marker for carcinomas and suggesting the potential importance of the large ncRNA in the molecular cell biology of neoplasia. MALAT-1 (i.e. alpha gene) is located at human chromosome 11q13 (van Asseldonk et al., 2000) , where chromosomal aberrations are observed for a broad range of human neoplasms including lung carcinomas, breast tumors, endocrine tumors and ovary and uterine carcinomas. Indeed, a chromosomal translocation of t(6;11)(p21.1;q13) is observed for primary renal tumors that results in the fusion of the alpha gene with TFEB, a basic helix-loop-helix leucine zipper (bHLH-LZ) transcription factor (Davis et al., 2003) , and upregulation of TFEB protein levels owing to promoter substitution (Kuiper et al., 2003) . Expression of the MALAT-1 gene was also increased in the metastasizing non-small-cell lung cancer compared with the non-metastasizing tumors (Ji et al., 2003) , and also upregulated in endometrial stromal sarcoma compared with the stroma of normal endometrium (Yamada et al, 2006) . These observations, in combination with our current study identifying MALAT-1 as a potentially generic marker for carcinomas, suggest the significant role of MALAT-1 in the molecular events of neoplasia.
Our study provides a model for analysis of the murine ortholog of MALAT-1, namely HCN, in hepatocarcinogenesis. DEN induces HCC through hepatocyte DNA damage, hepatocyte death and a compensatory proliferative responses (Sarma et al., 1986; Maeda et al., 2005) . It has been shown that ablation of expression of transcription factors c-Jun or Foxm1b, both participants in hepatocyte proliferation, inhibits DEN-induced HCC carcinogenesis (Eferl et al., 2003; Kalinichenko et al., 2004) . Currently, it is not known how the HCN transcript exerts its role in neoplasia. There are examples of large ncRNAs regulating transcription of other genes, for example, Xist (Brockdorff et al., 1992; Plath et al., 2002) and SRA (Lanz et al., 1999) . We speculate that HCN may be a riboregulator controlling expression of its targeted genes. The relatively large size of the HCN RNA permits formation of secondary structure and binding to other molecules such as transcription factors to exert regulatory roles. The predominant localization of HCN in tumor cell nuclei with frequent nucleolar concentration supports this hypothesis. One mechanism of nuclear retention of RNA is through A-to-I editing, post-transcriptional modification of adenosine (A) residues to inosine (I) (Bass, 2002) , as in a described 8-kb poly(A) þ RNA CTN-RNA (Prasanth et al., 2005) . However, we find no evidence of A-to-I editing in the HCN transcript (data not shown), suggesting other mechanisms for nuclear retention.
In conclusion, we have identified a large ncRNA transcript, Hepcarcin (HCN), apparently the murine ortholog of MALAT-1, that is a novel marker for carcinogen-induced HCCs and highly expressed in syngeneic murine colon carcinomas. We have also demonstrated that MALAT-1 is a marker with high sensitivity for human HCCs at both early and later stages, suggesting a potential diagnostic tool for HCCs. The large ncRNA was overexpressed as well in five non-hepatocellular human carcinomas, consistent with identity as a potentially generic marker for carcinomas and a significant role in neoplasia. This study also provides a murine model to investigate the role of the HCN large ncRNA in neoplasia. This model may expand knowledge of the roles of this and other related large ncRNAs in tumorigenesis and neoplasia.
Materials and methods
Cell culture CT26 murine colon carcinoma cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf Figure 5 MALAT-1 transcript in human carcinomas. The hAS probe was used for ISH. Intensity of reactions was scored as undetectable or low (0), moderate (1), strong (2) or very strong (3). NT, non-tumor; T, tumor. serum, 2 mM glutamine and 0.1 mM non-essential amino acids (Gibco, Carlsbad, CA, USA), in a humidified 8% CO 2 incubator at 371C.
Animals
For tumor grafts, 1-5 Â 10 5 syngeneic CT26 cells were injected subcutaneously on the back of Balb/c mice. When tumors were B0.8-1 cm in greatest dimension, the mice were killed and the tumor and other tissues were recovered. The procedures for animal studies were performed in the The Scripps Research Institute or facilities, and approved by the Institutional Animal Care and Use Committee. For the induction of liver tumors, 15-day-old C57BL/6/129 mice were injected intraperitoneally with 5 mg/kg DEN (Sigma, St Louis, MO, USA) as described previously . After 8 months on normal chow, all mice were killed. The livers were removed, separated into individual lobes and micro-dissected into tumor (X3 mm) and non-tumor tissues. These mice were maintained at the University of California, San Diego, according to NIH guidelines .
Human carcinoma samples
Microarray slides of formalin-fixed, paraffin-embedded human liver tumors or normal liver samples were purchased from Telechem International Inc. (Sunnyvale, CA, USA) Human liver tumor or normal liver total RNAs were purchased from Ambion (Austin, TX, USA).
In situ hybridization (ISH)
Murine tissues were fixed overnight in 10% buffered formalin, paraffin-embedded, and sectioned at 3 mm thickness. Sections were melted, dewaxed in xylene, rehydrated with 100% followed by 95% ethanol, then H 2 O. Tissues were treated with Target Retrieval (DAKO GenPoint, Carpinteria, CA, USA), digested with proteinase K according to the manufacturer's protocol and hybridized with 20 ng/ml digoxigenin (DIG)-labeled probe overnight at 501C. Sections were incubated with 1:50 anti-DIG-HRP (DAKO), reacted with biotinyl tyramide (DAKO Genepoint), and incubated with 1:200 anti-biotin-AP (Roche, Indianapolis, IN, USA). The signal was developed with red alkaline phosphatase substrate (Vector SK-5100) to produce a red precipitate at the hybridization site. Sections were counterstained with hematoxylin and mounted with permount (Fisher).
RNA isolation and Northern analyses
Murine RNA was isolated using Trizol (Invitrogen, Carlsbad, CA, USA) according to the protocol. Equal amount of total RNA was electrophoresed on 1% agarose gels containing 2% formaldehyde, transferred by capillary to positive charged nylon (Immobilon-Ny þ , Millipore, Billerica, MA, USA) overnight. The membranes were washed with 6 Â SSC, dried and UV crosslinked for 45 s at maximum intensity by Transilluminator (Fisher), and hydrated with milli-Q H 2 O. After prehybridizing with Ultrahyb (Ambion), membranes were hybridized in Ultrahyb containing 5 ng/ml DIG-labeled probe overnight at 681C. CDP-Star (Roche) kit using chemiluminescent technology was used to detect the RNA binding to DIG-labeled probes according to the vendor's protocol. Signals were developed by exposure to Kodak Biomax MR film then scanned, and the RNA was quantified by relative density of RNA bands with Scion Image software (Frederick, MD, USA).
Bioinformatics
Bioinformatic searches were performed with ORF Finder and BLAST (Basic Local Alignment Search Tool) from the NCBI. Align (Invitrogen) was used to make alignments of DNAs or putative proteins.
